CVS Health Corporation
CVS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $102,871,000 | $98,915,000 | $94,588,000 | $97,710,000 |
| % Growth | 4% | 4.6% | -3.2% | – |
| Cost of Goods Sold | $89,065,000 | $85,322,000 | $80,192,000 | $84,811,000 |
| Gross Profit | $13,806,000 | $13,593,000 | $14,396,000 | $12,899,000 |
| % Margin | 13.4% | 13.7% | 15.2% | 13.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $17,013,000 | $11,212,000 | $11,022,000 | $10,531,000 |
| Operating Expenses | $17,013,000 | $11,212,000 | $11,022,000 | $10,531,000 |
| Operating Income | -$3,207,000 | $2,381,000 | $3,374,000 | $2,368,000 |
| % Margin | -3.1% | 2.4% | 3.6% | 2.4% |
| Other Income/Exp. Net | -$275,000 | -$734,000 | -$757,000 | -$242,000 |
| Pre-Tax Income | -$3,482,000 | $1,647,000 | $2,617,000 | $2,126,000 |
| Tax Expense | $508,000 | $634,000 | $835,000 | $503,000 |
| Net Income | -$3,975,000 | $1,021,000 | $1,779,000 | $1,644,000 |
| % Margin | -3.9% | 1% | 1.9% | 1.7% |
| EPS | -3.13 | 0.81 | 1.41 | 1.31 |
| % Growth | -486.4% | -42.6% | 7.6% | – |
| EPS Diluted | -3.13 | 0.8 | 1.41 | 1.3 |
| Weighted Avg Shares Out | 1,269,000 | 1,266,000 | 1,261,000 | 1,259,000 |
| Weighted Avg Shares Out Dil | 1,269,000 | 1,270,000 | 1,264,000 | 1,261,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $784,000 | $763,000 | $785,000 | $758,000 |
| Depreciation & Amortization | $1,134,000 | $1,171,000 | $1,154,000 | $1,147,000 |
| EBITDA | -$1,564,000 | $3,581,000 | $4,556,000 | $4,027,000 |
| % Margin | -1.5% | 3.6% | 4.8% | 4.1% |